{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:22:35Z","timestamp":1777033355282,"version":"3.51.4"},"reference-count":45,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2023,6,8]]},"DOI":"10.1167\/tvst.12.6.3","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T14:31:10Z","timestamp":1686234670000},"page":"3","source":"Crossref","is-referenced-by-count":7,"title":["A Novel Device for Suprachoroidal Drug Delivery to Retina: Evaluation in Nonhuman Primates"],"prefix":"10.1167","volume":"12","author":[{"given":"Ygal","family":"Rotenstreich","sequence":"first","affiliation":[{"name":"The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel"},{"name":"The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifat","family":"Sher","sequence":"additional","affiliation":[{"name":"The Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel"},{"name":"The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"},{"name":"TELEM Rubin Excellence in Biomedical Research Program, Sheba Medical Center, Tel Hashomer, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Virscio, Inc., New Haven, CT, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Mangelus","sequence":"additional","affiliation":[{"name":"Everads Therapy Ltd., Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avner","family":"Ingerman","sequence":"additional","affiliation":[{"name":"AI Consultants, Brookline, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoreh","family":"Barak","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Rambam Health Care Campus, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob Health"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41433-021-01766-w","article-title":"An update on long-acting therapies in chronic sight-threatening eye diseases of the posterior segment: AMD, DMO, RVO, uveitis and glaucoma","volume":"36","author":"Ghanchi","year":"2022","journal-title":"Eye (Lond)"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.oret.2019.05.017","article-title":"Visual acuity outcomes and anti\u2013vascular endothelial growth factor therapy intensity in neovascular age-related macular degeneration patients: a real-world analysis of 49?485 eyes","volume":"4","author":"Ciulla","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ophtha.2010.12.019","article-title":"Safety and efficacy of a flexible dosing regimen of ranibizumab in neovascular age-related macular degeneration: the SUSTAIN study","volume":"118","author":"Holz","year":"2011","journal-title":"Ophthalmology"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ophtha.2018.11.019","article-title":"The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma: a report by the American Academy of Ophthalmology","volume":"126","author":"Hoguet","year":"2019","journal-title":"Ophthalmology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.survophthal.2010.08.006","article-title":"Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease","volume":"56","author":"Tolentino","year":"2011","journal-title":"Surv Ophthalmol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1167\/iovs.10-6291","article-title":"Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model","volume":"52","author":"Olsen","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejpb.2021.10.003","article-title":"Suprachoroidal delivery of bevacizumab in rabbit in vivo eyes: rapid distribution throughout the posterior segment","volume":"169","author":"Sher","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.ophtha.2015.06.041","article-title":"The risk of intraocular pressure elevation in pediatric noninfectious uveitis","volume":"122","author":"Kothari","year":"2015","journal-title":"Ophthalmology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.survophthal.2021.12.002","article-title":"Efficacy and safety of intravitreal and periocular injection of corticosteroids in non-infectious uveitis: a systematic review","volume":"67","author":"Jos\u00e9-Vieira","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2174\/1566523217666171116170040","article-title":"The role of gene therapy in the treatment of retinal diseases: a review","volume":"17","author":"Campa","year":"2017","journal-title":"Curr Gene Ther"},{"key":"bib13","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4103\/1673-5374.306063","article-title":"The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery","volume":"16","author":"Ross","year":"2021","journal-title":"Neural Regen Res"},{"key":"bib14","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.4103\/1673-5374.276324","article-title":"Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases","volume":"15","author":"Puertas-Neyra","year":"2020","journal-title":"Neural Regen Res"},{"key":"bib15","first-page":"3905","article-title":"Intravitreal autologous bone marrow CD34+ cell therapy for retinal vein occlusion: phase I\/II clinical trial","volume":"59","author":"Park","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0140-6736(17)30979-0","article-title":"Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial","volume":"390","author":"Heier","year":"2017","journal-title":"Lancet"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.omtm.2020.06.007","article-title":"Analysis of aflibercept expression in NHPs following intravitreal administration of ADVM-022, a potential gene therapy for nAMD","volume":"18","author":"Kiss","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pharmaceutics13020288","article-title":"Suprachoroidal delivery of small molecules, nanoparticles, gene and cell therapies for ocular diseases","volume":"13","author":"Wan","year":"2021","journal-title":"Pharmaceutics"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/17425247.2021.1867532","article-title":"Biomechanics of suprachoroidal drug delivery: from benchtop to clinical investigation in ocular therapies","volume":"18","author":"Hancock","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/pharmaceutics13070967","article-title":"Drug delivery via the suprachoroidal space for the treatment of retinal diseases","volume":"13","author":"Naftali Ben Haim","year":"2021","journal-title":"Pharmaceutics"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.addr.2018.03.001","article-title":"The suprachoroidal space as a route of administration to the posterior segment of the eye HHS public access","volume":"126","author":"Chiang","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jconrel.2022.05.061","article-title":"Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions","volume":"349","author":"Kansara","year":"2022","journal-title":"J Control Release"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"key":"bib25","first-page":"1139","article-title":"Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)","volume":"106","author":"Khurana","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17469899.2022.2114456","article-title":"Triamcinolone acetonide injectable suspension for suprachoroidal use in the treatment of macular edema associated with uveitis","volume":"17","author":"Thomas","year":"2022","journal-title":"Expert Rev Ophthalmol"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3928\/23258160-20180831-07","article-title":"Suprachoroidal space alterations following delivery of triamcinolone acetonide: post-hoc analysis of the phase 1\/2 HULK study of patients with diabetic macular edema","volume":"49","author":"Lampen","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1172\/JCI129085","article-title":"AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression","volume":"129","author":"Ding","year":"2019","journal-title":"J Clin Invest"},{"key":"bib29","first-page":"1497","article-title":"Suprachoroidal delivery of RGX-314 gene therapy for neovascular AMD: the phase II AAVIATE study","volume":"63","author":"Khanani","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2015.02.021","article-title":"Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model","volume":"203","author":"Chen","year":"2015","journal-title":"J Control Release"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.exer.2016.03.008","article-title":"Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries","volume":"145","author":"Chiang","year":"2016","journal-title":"Exp Eye Res"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ajo.2006.05.045","article-title":"Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment","volume":"142","author":"Olsen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000336045","article-title":"Safety of submacular suprachoroidal drug administration via a microcatheter: retrospective analysis of European treatment results","volume":"227","author":"Tetz","year":"2012","journal-title":"Ophthalmologica"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1007\/s10792-020-01471-9","article-title":"Efficacy and safety of injecting increasing volumes into the extravascular spaces of the choroid using a blunt adjustable depth injector","volume":"40","author":"Sher","year":"2020","journal-title":"Int Ophthalmol"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1111\/aos.2017.95.issue-3","article-title":"A minimally invasive adjustable-depth blunt injector for delivery of pharmaceuticals into the posterior pole","volume":"95","author":"Rotenstreich","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.exer.2013.10.023","article-title":"Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy","volume":"118","author":"Tzameret","year":"2014","journal-title":"Exp Eye Res"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"4061975","DOI":"10.1155\/2017\/4061975","article-title":"Long-term safety of transplanting human bone marrow stromal cells into the extravascular spaces of the choroid of rabbits","volume":"2017","author":"Tzameret","year":"2017","journal-title":"Stem Cells Int"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3109\/02713683.2015.1056374","article-title":"Imaging suprachoroidal layer in exudative age-related macular degeneration","volume":"41","author":"Kim","year":"2016","journal-title":"Curr Eye Res"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","article-title":"Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the Tanzanite Study","volume":"2","author":"Campochiaro","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/S0161-6420(98)96008-0","article-title":"Histologic localization of indocyanine green dye in aging primate and human ocular tissues with clinical angiographic correlation","volume":"105","author":"Chang","year":"1998","journal-title":"Ophthalmology"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1023\/A:1005880129005","article-title":"Indocyanine green angiography in central serous chorioretinopathy ICG angiography in CSC","volume":"21","author":"Menchini","year":"1997","journal-title":"Int Ophthalmol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0161-6420(89)32826-0","article-title":"Indocyanine Green videoangiography of choroidal neovascularization","volume":"96","author":"Destro","year":"1989","journal-title":"Ophthalmology"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejpb.2021.10.003","article-title":"Suprachoroidal delivery of bevacizumab in rabbit in vivo eyes: rapid distribution throughout the posterior segment","volume":"169","author":"Sher","year":"2021","journal-title":"Eur J Pharm Biopharm"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12951-018-0438-y","article-title":"In vivo MRI assessment of bioactive magnetic iron oxide\/human serum albumin nanoparticle delivery into the posterior segment of the eye in a rat model of retinal degeneration","volume":"17","author":"Tzameret","year":"2019","journal-title":"J Nanobiotechnology"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"eaba1606","DOI":"10.1126\/sciadv.aba1606","article-title":"Suprachoroidal gene transfer with nonviral nanoparticles","volume":"6","author":"Shen","year":"2020","journal-title":"Sci Adv"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2785682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T14:31:16Z","timestamp":1686234676000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2785682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.12.6.3","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}